Skip to main content
Premium Trial:

Request an Annual Quote

Sciex, Protein Metrics Partner on Mass Spec Data Analysis

NEW YORK – Sciex and Protein Metrics said today that they have partnered to more thoroughly connect Protein Metrics' software suite and Sciex's high-resolution accurate mass (HRAM) spectrometry systems.

Specifically, the companies are linking Protein Metrics' Byos protein characterization software with Sciex's X500 Systems in an attempt to create an open data-analysis ecosystem that will allow biopharmaceutical companies to bring therapeutics to market more quickly, the companies noted in a statement.

The partners began integrating their products more than four years ago with Sciex's TripleTOF 5600 and Triple TOF 6600 LC-MS/MS Systems, enabling customers to track quality attributes for batches of therapeutic protein peptide maps and to characterize and quantify post-translational modifications and sequence variants.

"This demonstrates our commitment to providing an open platform that enables researchers to use the processing software of their choice with our instruments," Fraser McLeod, vice president and general manager for software at Sciex, said in a statement. "We look forward to continuing our collaborative partnership with new product launches."

The Scan

Octopus Brain Complexity Linked to MicroRNA Expansions

Investigators saw microRNA gene expansions coinciding with complex brains when they analyzed certain cephalopod transcriptomes, as they report in Science Advances.

Study Tracks Outcomes in Children Born to Zika Virus-Infected Mothers

By following pregnancy outcomes for women with RT-PCR-confirmed Zika virus infections, researchers saw in Lancet Regional Health congenital abnormalities in roughly one-third of live-born children.

Team Presents Benchmark Study of RNA Classification Tools

With more than 135 transcriptomic datasets, researchers tested two dozen coding and non-coding RNA classification tools, establishing a set of potentially misclassified transcripts, as they report in Nucleic Acids Research.

Breast Cancer Risk Related to Pathogenic BRCA1 Mutation May Be Modified by Repeats

Several variable number tandem repeats appear to impact breast cancer risk and age at diagnosis in almost 350 individuals carrying a risky Ashkenazi Jewish BRCA1 founder mutation.